Clinical Trial Update: Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update describing the status of using docosahexaenoic acid (DHA) as neoadjuvant therapy for women with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Docosahexaenoic acid (DHA) (docosahexaenoic acid)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING